Therefore, the current study first used bioinformatic analyses to observe that KIFC1 expression was increased in pancreatic cancer and positively correlated with tumor mutation burden, tumor purity, mismatch repair, and KRAS and TP53 mutation. This evidence concerns the gene KRAS and pancreatic neoplasm.